Mytos
BrazilHealthtech
Mytos automates cell manufacturing for life science companies, solving the challenge of culturing human cells with precision and efficiency. Its platform enables unprecedented control over cell production processes. The company serves clients in the life sciences sector, likely across LATAM and possibly globally. It raised USD$19 million in funding, indicating significant traction in the healthtech space.
1 funding rounds tracked. Follow the profile to review the shared record and its sources.
Open profile
Open profile